SCHEMBL24316089

SCHEMBL24316089

CNC(=O)CCC(C=O)N1C(=O)c2ccc(N3CCN(Cc4ccccc4)CC3)c3cccc1c23

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 2/20 0.38
DRD2 P14416 2/20 0.38
DRD4 P21917 2/20 0.38
DRD3 P35462 2/20 0.38
MEN1 O00255 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
TLR9 Q9NR96 1/20 0.38
HTR1A P08908 1/20 0.37
LMNA P02545 1/20 0.37
BACE1 P56817 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HTR7 P34969 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24316240 0.78 CYP1B1 (0.41) MAPTL3MBTL1ALDH1A1MEN1HTT
SCHEMBL24315752 0.75 HDAC8 (0.40) L3MBTL1HTR1ALMNA
SCHEMBL24315912 0.74 KDM4E (0.34) MAPTALDH1A1HTTKMT2ALMNA
SCHEMBL24315949 0.74 KDM4E (0.32)
SCHEMBL24315846 0.72 LMNA (0.39) MAPTDRD2MEN1KMT2AHTR1A
SCHEMBL24317938 0.72 ALDH1A1 (0.39) MAPTNPSR1ALDH1A1MEN1KMT2A
SCHEMBL24316313 0.72 UBE2M (0.39) ALDH1A1DRD4MEN1KMT2ALMNA
SCHEMBL24317937 0.71 KMT2A (0.41) MAPTL3MBTL1TDP1ALDH1A1MEN1
SCHEMBL7121196 0.69 L3MBTL1 (0.54) MAPTL3MBTL1NPSR1TDP1ALDH1A1
SCHEMBL7121956 0.69 MEN1 (0.48) MAPTL3MBTL1NPSR1TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081925-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed